Vaccinia-measles recombinant viruses were used to examine the contribution of the individual measles virus glycoproteins in fusion. Although vaccinia virus recombinants expressing either the haemagglutinin or fusion proteins did not induce fusion in the cell lines examined, a double recombinant expressing both measles virus glycoproteins gave extensive syncytia in cells of human and simian origin. No fusion was observed in mouse, hamster or chicken cells. The fusion induced by the double recombinant could be specifically inhibited with either anti-fusion or antihaemagglutinin monoclonal antibodies.
The entry of enveloped viruses into cells occurs either by fusion at the cell membrane or after endocytosis in the lysosomes (for a review see Marsh & Helenius, 1988) . Whereas paramyxovirus fusion occurs at the cell surface, retroviruses utilize both mechanisms, but the fusion proteins of the human immunodeficiency viruses, HIV-1 and HIV-2, which are organized in a manner similar to those of the paramyxoviruses, have been shown to exhibit pH-independent fusion (McClure et al., 1987; Stein et al., 1987) . In the majority of enveloped viruses, membrane fusion is mediated through the fusogenic spike proteins which are also responsible for attachment to the target cell. In the paramyxoviruses the functions of attachment and fusion are mediated by two separate proteins. Although fusion as one of the initial steps of viral infection is an obvious target for antiviral agents, the actual mechanism in terms of the proteins involved and their conformational changes remains relatively obscure.
As with other paramyxoviruses, measles virus (MV) infections are initiated by the attachment of the virus to the host cell by the haemagglutinin (H) glycoprotein, whereas penetration into the cell is mediated by the interaction of the fusion (F) glycoprotein with the cell membrane. In the later stages of infection the newly synthesized glycoproteins accumulate at the cell membrane resulting in fusion with the neighbouring cells to produce syncytia. Thus infection can pass from cell to cell without the necessity of producing complete virus particles. During MV infections in man, once antibodies have eliminated virus from the circulation, the main route of infection is probably by cell-to-cell transmission. Studies with a number of viruses that induce syncytia suggest that the mechanism is complex. In HIV infection the host cells must not only have the CD4 virus receptor (Dalgleish et al., 1984; Klatzmann et al., 1984) but also a second undefined component(s) in the cell membrane which determines penetration and syncytium formation (Ashorn et al., 1990) .
Whether both glycoproteins are necessary for fusion to occur in MV is open to debate. In our studies, we have expressed recombinant vaccinia viruses containing either the H or the F genes ofMV (Drillien et al., 1988) in cells of human and non-human origin and have never observed syncytium formation. Studying bovine parainfluenza virus 3, Sakai & Shibuta (1989) concluded that both viral glycoproteins were necessary, as studies showed that fusion of indicator cells could be obtained only by doubly infecting cells with vaccinia virus recombinants containing the H and F genes. Recently however, Alkhatib et al. (1990) have shown that adenovirus recombinants expressing the MV F gene cause fusion in 293 (human) cells.
To investigate this phenomenon further, we have used a vaccinia virus double recombinant in which both of the MV H and F genes are expressed. In the present study we show that such a recombinant gives rise directly to syncytia. The phenomenon is host cell-dependent and can be inhibited by antibodies directed against either the H or F antigen.
In previous studies we successfully expressed MV H and F genes from the 7.5K promoter of the thymidine kinase (TK) gene of vaccinia virus (Drillien et al., 1988) . In the present work, a double recombinant was constructed by inserting both genes in opposite orientations behind the 7.5K promoter of the TK gene (R. Drillien et 0000-9919 © 1991 SGM Cell lysates were prepared, the MV proteins immunoprecipitated with a mixture of anti-H and anti-F monoclonal antibodies and analysed by SDS-PAGE as previously described (Drillien et al., 1988) . The arrows mark the positions of H, Fo, F~ and F2.
al., unpublished results). To establish whether the H and F genes are expressed in this type of construction, HeLa cells were infected with vaccinia virus recombinants containing either the H (VV-H), F (VV-F), or both MV genes (VV-H/F), for 18 h and then radiolabelled with [35S]methionine for 5 h. Cell lysates were prepared and the virus proteins were immunoprecipitated with a mixture of anti-H and anti-F MV monoclonal antibodies and analysed by SDS-PAGE (Fig. 1) . The VV-H recombinant gave a double band at approximately 80K (presumably reflecting differential glycosylation), whereas VV-F gave bands representing the uncleaved fusion protein, F o (60K) and two further bands F 1 (40K) and F 2 (20K) resulting from the cleavage of F0. Cells infected with the double recombinant (VV-H/F) expressed both the H and F MV proteins, although the amount of F expressed was less than in the single recombinant infections. A further band was observed at approximately 70K and was specific for recombinants expressing the F gene and immunoprecipitated with monoclonal antibody to the denatured form of F1. The nature of this * Haemagglutination inhibition (HI) was measured as previously described (Norrby & GoUmar, 1972) .
t Fusion inhibition (FI). HeLa ceils in 96-well plates (40000 cells/well) were infected with the recombinant VV-H/F at an m.o.i, of 0.01 p.f.u./cell and dilutions of monoclonal antibodies were added I h later. The cells were examined 18 h later for fusion.
protein is under investigation. Immunofluorescence studies on unfixed VV-H/F-infected cells confirmed our previous results with the single recombinants that both antigens are expressed at the cell membrane. Also, VV-H-or VV-H/F-infected cells were positive in a haemadsorption assay with monkey (vervet) red blood cells, but cells infected with the VV-F recombinant virus were not (data not shown).
To investigate syncytium formation, confluent monolayer cultures of HeLa cells were infected with either the single (VV-H, VV-F) or double (VV-H/F) recombinants and examined 18 h later (Fig. 2) . Syncytia were observed only in the VV-H/F-infected cells. Similar results were obtained in HL60 (human promyelocyte) CEM (human T) and Vero (monkey) cell lines (Table 1 ). In contrast, cells which are non-permissive for MV, such as L929 (mouse) and BHK (hamster) did not give syncytia when infected with the double recombinant VV-H/F. These observations are not due to uncleaved F, as the F~ and F2 proteins were observed in VV-Finfected BHK cells (Drillien et al., 1988) . With the exception of chick embryo fibroblasts which do not form syncytia with VV-H/F but support MV replication, induction of syncytia by VV-H/F is related to the permissiveness of the cell line to MV infection. This may suggest that these cells contain a component which acts as a receptor during syncytium formation.
To characterize the VV-H/F-induced fusion in HeLa cells we tested the ability of anti-F and anti-H monoclonal antibodies to inhibit syncytia (Table 2) . Anti-F monoclonal antibodies prepared against purified MV (gifts from E. Norrby, Stockholm, Sweden and Y. Boriskin, Moscow, U.S.S.R.) neither neutralized measles virus infectivity nor inhibited syncytia. In contrast, anti-F monoclonal antibodies prepared from mice immunized with VV-F (Malvoisin & Wild, 1990b) neutralized MV infectivity and inhibited VV-H/F-and MV-induced fusion. The anti-H monoclonal antibodies also inhibited syncytium formation confirming the role of the H glycoprotein in the fusion process.
The specificity of the syncytium formation induced by the recombinant vaccinia virus was further verified by the use of the tripeptide D-Phe-L-Phe-z-Gly. This is an analogue of the N terminus of the F1 polypeptide of MV and specifically inhibits virus penetration and cell fusion (Norrby, 1971 ; Richardson et al., 1980) . When VV-H/Finfected HeLa cells were incubated in the presence of 10 ~tg/ml of the peptide (a concentration that inhibits syncytium formation by MV) there was a complete inhibition of fusion.
Although a wide variety of agents can cause cells to fuse, the number of viruses that exhibit this effect is limited. The observation that HIV belongs to this group of viruses has led to a re-examination of the mechanism involved and its relationship to the immunopathological state. Our studies to investigate some of the parameters involved in cell fusion induced by MV have shown that both the H and F glycoproteins are necessary. Presumably the H antigen is required to initiate the process as cells in which MV does not replicate (probably because they lack the MV receptor) do not form syncytia. In contrast, Alkhatib et al. (1990) observed fusion with adenovirus recombinants expressing the MV F gene. The high level of expression of the F protein in this system may be one explanation, but an adenovirus protein may also play a role.
The lack of fusion in systems other than human or simian could be due to the presence of inhibitors. Mouse-human somatic cell hybrids containing nearly all the human chromosomes and expressing human proteins, including CD4, at the cell membrane, do not give syncytia when infected with HIV or vaccinia virus recombinants containing the HIV glycoprotein (Ters-Short communication mette et al., 1989; Ashorn et al., 1990) . This may suggest that mouse cell membranes contain inhibitors of fusion activity. Furthermore, the ability of cells to fuse can be influenced by changes in the concentration of cholesterol in the membrane (Malvoisin & Wild, 1990a) and by the ratio of saturated to non-saturated fatty acids (Ross et al., 1990) . Thus, it would appear to be possible to alter the ability of cells to fuse by manipulation of the lipid composition of the cell membrane. This may play a special role in the immunopathology of MV, as it infects a number of different types of cells which may differ in their membrane composition. The use of the vacciniameasles recombinant viruses will be an ideal system for the study of some of these parameters.
